Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.
China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...
Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...
There is no cure for vitiligo, but there are a variety of innovative treatments that your doctor may prescribe once you've been diagnosed. It's a really exciting time to be treating vitiligo ...
In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...
Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.
Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...
"So if it's possible, try to add phototherapy for your vitiligo patients, but sometimes, logistics for that are a challenge." Discussing treatment expectations with patients is key because it can ...
Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...
Treatment options such as topical steroids, light therapy, and cosmetic camouflage are available to help manage the appearance of vitiligo, but they do not cure the condition. Varma’s openness ...
In some cases, a skin biopsy may be necessary. It is not possible to cure vitiligo. However, certain treatments can help restore color to affected areas of skin and reduce spread. Some treatments ...
VASI is a valid and reliable tool that is responsive to change and has defined thresholds for meaningful improvement for patients with vitiligo.